Nuo Therapeutics, Inc. (AURX)

EBITDA

-$1.56M

TTM · Period ending: · USD

AURX logo

AURX EBITDA

Latest reported-$1.56M
AURX EBITDA (-$3.50M → -$1.56M)
High-resolution chart · PNG

AURX ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-2,359,710
-2,361,566
-3,063,016
-3,095,554
0
-288,200
-879,339
-1,400,745
-13,854,041
-6,746,365
-48,355,549
-14,815,406
-17,457,609
-17,559,367
-1,812,855
-5,563,901
-3,214,290
-7,489,982
-4,879,942
-3,962,070
-6,279,211
-4,872,150
-2,940,029
-1,880,880
-4,038,656
-33,352,211
-3,504,803
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.